Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Ziyad Makoshi

Neurological Surgery El Paso, TX Medical Doctor

NPI 1083238000 CMS profile 8499200

4815 Alameda Ave, El Paso, TX 79905

Open in the dashboard

General payments

$1,664

38 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ziyad Makoshi of El Paso, TX is reported in the CMS Open Payments database as having received $1,664 across 38 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 39th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $262 10
2024 General $1,114 14
2023 General $289 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ziyad Makoshi
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Ziyad Makoshi were reported at $262. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Ziyad Makoshi Neurological Surgery median Middle half National median
2019 $0 $582 $138–$3,006 $163
2020 $0 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $0 $542 $139–$2,989 $149
2023 $289 $534 $145–$2,697 $160
2024 $1,114 $574 $155–$3,046 $164
2025 $262 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Aesculap, Inc. $1,094 13 payments
  2. Medtronic, Inc. $235 12 payments
  3. Stryker Corporation $164 6 payments
  4. UCB, Inc. $124 5 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $28 1 payment
  6. Regeneron Healthcare Solutions, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $859 31 payments
  2. Travel and Lodging $806 7 payments
Products named General payments · program years 2023–2025
  1. NO APPLICABLE MARKETED PRODUCT NAME $1,083 12 payments
  2. N/A Navigation $84 2 payments
  3. STRATA $72 4 payments
  4. STEALTHSTATION S8 PLATFORM $68 3 payments
  5. Fintepla $67 3 payments
  6. AQUAMANTYS(TM) $42 2 payments
  7. MAZOR X SYSTEM $40 2 payments
  8. N/A Neuro Spine Ent $35 2 payments
  9. Briviact $34 1 payment
  10. MESA SPINAL SYSTEM $29 1 payment
  11. Other $112 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

38 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record